Marczylo Timothy H, Lam Patricia M W, Nallendran Vijaianitha, Taylor Anthony H, Konje Justin C
Endocannabinoid Research Group, Reproductive Sciences Section, Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester, Leicestershire LE27LX, UK.
Anal Biochem. 2009 Jan 1;384(1):106-13. doi: 10.1016/j.ab.2008.08.040. Epub 2008 Sep 18.
N-Arachidonoylethanolamine (AEA, anandamide) was the first endocannabinoid to be identified and has since become associated with the mediation of several physiological functions and disease states. AEA has been isolated from numerous tissues and biofluids, in the low nanomolar range, using lipid extraction techniques with organic solvents. These techniques require the drying down of relatively large volumes of solvents, making them unsuitable for high-throughput analysis. Here we describe a solid-phase extraction (SPE) method for the investigation of AEA concentrations in human plasma, serum, milk, urine, amniotic fluid, peritoneal fluid, saliva, follicular fluid, and fluid from an ovarian cyst. AEA was detected in serum and plasma from blood isolated from 20 adult women (means+/-standard deviations: 0.68+/-0.29 and 0.64+/-0.28 nM, respectively), from pregnant women at term (1.37+/-0.42 nM), and from umbilical vein (1.26+/-0.33 nM) and umbilical artery (1.14+/-0.35nM), in milk (0.12+/-0.05 nM) and from amniotic (0.03+/-0.02 nM), peritoneal (0.93+/-0.27 nM), follicular (1.17+/-0.51 nM), and ovarian cyst (0.32+/-0.01 nM) fluids. AEA was undetectable in saliva and urine. The 60% AEA extraction efficiency achieved with SPE from plasma was superior to the 19% efficiency achieved using the existing organic solvent extraction method. Limits of quantification and detection for AEA were also improved dramatically using SPE (8 and 4 fmol/ml) compared with organic extraction (25 and 18.75 fmol/ml plasma). These improvements allow the use of smaller plasma samples with SPE. Intra- and interday variability were comparable, and the mean AEA concentration of pooled plasma samples (1.18 nM, n=15) was identical with the two techniques. Similarly, when 56 plasma samples from laboring and nonlaboring women were analyzed using both techniques, no extraction method-dependent differences were observed. Consequently, we provide evidence for a robust SPE technique for the extraction of AEA from biomatrices to replace the existing liquid extraction methods, with the SPE technique being superior in terms of speed, extraction efficiency, and sample size required.
N-花生四烯酰乙醇胺(AEA,花生四烯酸乙醇胺)是首个被鉴定出的内源性大麻素,自那以后它与多种生理功能及疾病状态的调节相关联。使用有机溶剂脂质提取技术,已在低纳摩尔范围内从众多组织和生物流体中分离出AEA。这些技术需要将相对大量的溶剂蒸发干燥,这使得它们不适用于高通量分析。在此,我们描述一种固相萃取(SPE)方法,用于研究人血浆、血清、乳汁、尿液、羊水、腹腔液、唾液、卵泡液以及卵巢囊肿液中的AEA浓度。在从20名成年女性分离的血液的血清和血浆中检测到了AEA(均值±标准差:分别为0.68±0.29和0.64±0.28 nM)、足月孕妇的血液中(1.37±0.42 nM)、脐静脉血(1.26±0.33 nM)和脐动脉血(1.14±0.35 nM)、乳汁中(0.12±0.05 nM)以及羊水(0.03±0.02 nM)、腹腔液(0.93±0.27 nM)、卵泡液(1.17±0.51 nM)和卵巢囊肿液(0.32±0.01 nM)中检测到了AEA,但在唾液和尿液中未检测到。采用SPE从血浆中提取AEA的效率达60%,优于现有的有机溶剂提取方法19%的效率值。与有机提取法(血浆中为25和18.75 fmol/ml)相比,使用SPE法时AEA的定量限和检测限也显著改善(分别为8和4 fmol/ml);这些改进使得使用SPE法时可以采用更小的血浆样本。日内和日间变异性相当,两种技术对混合血浆样本(1.18 nM,n = 15)的平均AEA浓度测定结果相同。同样,当使用两种技术对56份临产和未临产女性的血浆样本进行分析时,未观察到与提取方法相关的差异。因此,我们提供了证据证明一种用于从生物基质中提取AEA的可靠SPE技术,该技术可取代现有的液体提取方法,在速度、提取效率和所需样本量方面,SPE技术更具优势。